Retreatment of patients who do not respond to initial therapy for chronic hepatitis C

Article Type
Changed
Display Headline
Retreatment of patients who do not respond to initial therapy for chronic hepatitis C
Article PDF
Author and Disclosure Information

Mitchell L. Shiffman, MD
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, Va.

Correspondence: Mitchell L. Shiffman, MD, Chief, Hepatology Section, Virginia Commonwealth University Medical Center, Box 980341, Richmond, VA 23298; e-mail: mlshiffm@vcu.edu

Dr. Shiffman reported that he receives grant or research support from the Roche, Schering-Plough, InterMune, Isis, and Ortho Biotech corporations; serves as a consultant to the Roche and Isis corporations; and is on the speakers’ bureaus of the Roche, Schering-Plough, and Ortho Biotech corporations.

Publications
Page Number
S13-S16
Author and Disclosure Information

Mitchell L. Shiffman, MD
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, Va.

Correspondence: Mitchell L. Shiffman, MD, Chief, Hepatology Section, Virginia Commonwealth University Medical Center, Box 980341, Richmond, VA 23298; e-mail: mlshiffm@vcu.edu

Dr. Shiffman reported that he receives grant or research support from the Roche, Schering-Plough, InterMune, Isis, and Ortho Biotech corporations; serves as a consultant to the Roche and Isis corporations; and is on the speakers’ bureaus of the Roche, Schering-Plough, and Ortho Biotech corporations.

Author and Disclosure Information

Mitchell L. Shiffman, MD
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, Va.

Correspondence: Mitchell L. Shiffman, MD, Chief, Hepatology Section, Virginia Commonwealth University Medical Center, Box 980341, Richmond, VA 23298; e-mail: mlshiffm@vcu.edu

Dr. Shiffman reported that he receives grant or research support from the Roche, Schering-Plough, InterMune, Isis, and Ortho Biotech corporations; serves as a consultant to the Roche and Isis corporations; and is on the speakers’ bureaus of the Roche, Schering-Plough, and Ortho Biotech corporations.

Article PDF
Article PDF
Page Number
S13-S16
Page Number
S13-S16
Publications
Publications
Article Type
Display Headline
Retreatment of patients who do not respond to initial therapy for chronic hepatitis C
Display Headline
Retreatment of patients who do not respond to initial therapy for chronic hepatitis C
Citation Override
Cleveland Clinic Journal of Medicine 2004 May;71(suppl 3):S13-S16
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media